Serving as a focal point bridging energy metabolism and compromised innate immunity, FGF21 holds promise as a potential target for the diagnosis and treatment of DKD.As research interest burgeons around the multifaceted functions and pharmacological potential of FGF21, it has become a focal point in recent years (15). This evidence concerns the gene FGF21 and diabetic kidney disease.